sc-4289 sc-4289 sc-4289 is a synthetic nonsteroidal estrogen which, along with mytatrienediol (sc-6924; manvene, anvene), was developed in the late 1950s as a potential treatment for atherosclerosis in men but was never marketed. sc-4289clinical dataother names6-propyl-β-naphthol-2-benzyl etherroutes ofadministrationby mouthdrug classnonsteroidal estrogenidentifiers iupac name 2,2-dimethyl-3-(6'-benzyloxy-2'-naphthyl)pentanol chemical and physical dataformulac24h28o2molar mass348.486 g·mol−13d model (jsmol)interactive image smiles ccc(c1=cc=c2c=c(occ3=cc=cc=c3)c=cc2=c1)c(c)(c)co